
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Chem. , 04 February 2022
Sec. Chemical Biology
Volume 10 - 2022 | https://doi.org/10.3389/fchem.2022.842171
This article is part of the Research Topic COVID-19: Targeting Essential SARS-CoV-2 Proteins for Drug Discovery View all 14 articles
This article is a correction to:
Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences
A Corrigendum on
Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences
by Hegde, S., Tang, Z., Zhao, J., and Wang, J. (2021). Front. Chem. 9:802766. doi:10.3389/fchem.2021.802766
In the original article, there was a mistake in Figure 4 as published. Figure 4 was a duplication of Figure 6. The corrected Figure 4 appears below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: SARS-CoV-2, antiviral, RNA-targeting, small molecule, antisense oligonucleotide, untranslated region, programmed frameshift, RIBOTAC
Citation: Hegde S, Tang Z, Zhao J and Wang J (2022) Corrigendum: Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences. Front. Chem. 10:842171. doi: 10.3389/fchem.2022.842171
Received: 23 December 2021; Accepted: 11 January 2022;
Published: 04 February 2022.
Edited and reviewed by:
Jun Wang, Rutgers, The State University of New Jersey, United StatesCopyright © 2022 Hegde, Tang, Zhao and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jingxin Wang, d2FuZy5qaW5neGluQGt1LmVkdQ==
†These authors have contributed equally to this work
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.